Ticker Details
Adaptive Biotechnologies Corporation
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.26%
Avg Daily Range (30 D):	$0.34 | 2.45%
Avg Daily Range (90 D):	$0.41 | 2.73%

Institutional Daily Volume
Avg Daily Volume:	1.12M
Avg Daily Volume (30 D):	1.39M
Avg Daily Volume (90 D):	1.58M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	3,005
Avg Institutional Trade:	$1.98M
Avg Institutional Trade (30 D):	$2.16M
Avg Institutional Trade (90 D):	$2.75M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.5M
Avg Closing Trade (30 D):	$3.1M
Avg Closing Trade (90 D):	$3.74M
Avg Closing Volume:	154.09K

News

May 4, 2026 @ 9:29 PM Adaptive Biotechnologies' Chief Operating Officer ... Source: Robert Izquierdo

Apr 18, 2026 @ 2:37 PM Should You Sell Adaptive Biotechnologies (ADPT) Af... Source: Cory Renauer

Apr 8, 2026 @ 1:13 PM Adaptive Biotech Insider Sells $554K as Revenue Ju... Source: Jonathan Ponciano

Mar 31, 2026 @ 12:08 AM Adaptive Biotech's President Trimmed Her Position.... Source: Seena Hassouna

Mar 26, 2026 @ 4:13 PM Adaptive Biotech Insider Sale of 180,000 Shares Ti... Source: Jonathan Ponciano

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.33	$-.13	$-.09
Diluted EPS	$-.33	$-.13	$-.09
Revenue	$295.41M	$70.87M	$71.68M
Gross Profit	$222.32M	$52.17M	$53.46M
Net Income / Loss	$-49.64M	$-20.02M	$-13.58M
Operating Income / Loss	$-46.73M	$-19.21M	$-12.77M
Cost of Revenue	$73.09M	$18.71M	$18.22M
Net Cash Flow	$26.93M	$7.11M	$15.46M
PE Ratio